Skip to main content
. 2022 Aug 30;22(10):851–856. doi: 10.1111/ggi.14469

Table 1.

Baseline data of the participants (N = 317)

Characteristic Total (n = 317) FS ≧3 (n = 175) FSQ ≧3 (n = 149) CFS ≧5 (n = 220)
Age (years), median (IQR) 83.0 (13.0) 83.0 (9.0) 84.0 (9.0) 84.0 (9.0)
Male, n (%) 159 (50.2) 78 (44.6) 58 (38.9) 96 (43.7)
BMI (kg/m2), median (IQR) 22.9 (6.5) 21.8 (6.7) 22.0 (6.9) 22.0 (6.5)
Never smoking, n (%) 180 (56.8) 98 (56.0) 90 (60.4) 90 (40.9)
Chronic diseases, n (%)
Hypertension 204 (64.4) 116 (66.3) 98 (65.8) 140 (63.6)
Diabetes 118 (37.2) 74 (42.3) 54 (36.2) 82 (37.3)
Coronary heart disease 142 (44.8) 96 (54.9) 79 (53.0) 105 (47.7)
Hyperlipidemia 113 (35.6) 72 (41.1) 58 (38.9) 82 (37.3)
Chronic kidney disease 29 (9.1) 21 (12.0) 14 (9.4) 23 (10.5)
Stroke 64 (20.2) 37 (21.1) 33 (22.1) 48 (21.8)
COPD 61 (19.2) 43 (24.6) 36 (24.2) 54 (24.5)
Diagnosis on admission, n (%)
Pneumonia 146 (46.1) 100 (57.1) 85 (57.0) 118 (53.6)
Cerebral ischemic stroke 44 (13.9) 12 (6.9) 6 (4.0) 18 (8.2)
AECOPD 48 (15.1) 36 (20.6) 31 (20.8) 44 (20.0)
Heart failure 49 (15.5) 41 (23.4) 28 (18.8) 42 (19.1)
ACS 24 (7.6) 16 (9.1) 12 (8.1) 18 (8.2)
Anemia 138 (43.5) 95 (54.3) 82 (55.0) 111 (50.5)
NRS2002 score, median (IQR) 4 (3) 5 (4) 5 (4) 4 (5)
Barthel index, n (%)
61–100 167 (52.7) 59 (33.7) 47 (31.5) 73 (33.2)
41–60 62 (19.6) 39 (22.3) 33 (22.1) 59 (26.8)
≤40 88 (27.7) 77 (44.0) 69 (46.4) 88 (40.0)

ACS, acute coronary syndrome; AECOPD, acute exacerbation of chronic obstructive pulmonary disease; BMI, body mass index; CFS, clinical frailty scale; COPD, chronic obstructive pulmonary disease; FS, FRAIL scale; FSQ, frailty screening questionnaire; IQR, interquartile range; NRS, nutritional risk screening.